<p>Celularity Inc. held its Annual Meeting of Stockholders on December 19, 2025. Stockholders elected Peter Diamandis, M.D., Diane Parks, and Geoffrey Ling, M.D. to the Board of Directors. Stockholders ratified the appointment of EisnerAmper LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025. An amendment to increase the number of shares available under the 2021 Equity Incentive Plan was not approved. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Celularity Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-028560), on December 19, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

CELU

<p>Celularity Inc. held its Annual Meeting of Stockholders on December 19, 2025. Peter Diamandis, Diane Parks, and Geoffrey Ling were elected to the Board of Directors. EisnerAmper LLP was ratified as the independent public accounting firm for 2025. An amendment to increase shares under the 2021 Equity Incentive Plan was not approved.</p>

Celularity Inc. held annual stockholder meeting